GlassScriptPhysician profile
Ruben J Pipek
NPI 1952385981
$55,434.97
in general payments reported to CMS, 2019-2025
35 companies · $797 in 2025
The $797 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $6,837 · 2021: $6,503 · 2022: $924 · 2023: $671 · 2024: $910 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,378.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $25,572.67 | 2019-2025 | |
| Novo Nordisk INC | $9,591.36 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $8,684.64 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $6,562.76 | 2019-2022 | |
| Mannkind Corporation | $1,715.74 | 2019-2024 | |
| Abbvie INC. | $522.07 | 2019-2025 | |
| Tandem Diabetes Care, INC. | $395.36 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $307.28 | 2019-2022 | |
| Amgen INC. | $199.04 | 2020-2025 | Evenity, Prolia, Tepezza |
| Abbott Laboratories | $177.42 | 2019-2025 | Freestyle Libre 3 |
| Corcept Therapeutics | $168.99 | 2020-2025 | Korlym |
| Lilly USA, LLC | $162.94 | 2019-2025 | Jardiance, Lyumjev, Zepbound |
| Medtronic, INC. | $161.14 | 2022-2024 | Minimed 780g |
| Radius Health, INC. | $151.03 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $141.65 | 2019-2021 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruben Pipek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.